Terms: = Liver cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Diagnosis
4 results:
1. The association between klf4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection.
Xue M; Zhou C; Zheng Y; Zhang Z; Wang S; Fu Y; Atyah M; Xue X; Zhu L; Dong Q; Jia H; Ren N; Hu R
Aging (Albany NY); 2020 Aug; 12(15):15566-15580. PubMed ID: 32756012
[TBL] [Abstract] [Full Text] [Related]
2. miR-124 inhibits progression of hepatocarcinoma by targeting klf4 and promises a novel diagnostic marker.
Wu LP; Wu J; Shang A; Yang M; Li LL; Yu J; Xu LR; Wang CB; Wang WW; Zhu JJ; Lu WY
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):159-167. PubMed ID: 29252002
[TBL] [Abstract] [Full Text] [Related]
3. Barrier to autointegration factor 1, procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3, and splicing factor 3b subunit 4 as early-stage cancer decision markers and drivers of hepatocellular carcinoma.
Shen Q; Eun JW; Lee K; Kim HS; Yang HD; Kim SY; Lee EK; Kim T; Kang K; Kim S; Min DH; Oh SN; Lee YJ; Moon H; Ro SW; Park WS; Lee JY; Nam SW
Hepatology; 2018 Apr; 67(4):1360-1377. PubMed ID: 29059470
[TBL] [Abstract] [Full Text] [Related]
4. Identification of a non-coding klf4 transcript generated from intron retention and downregulated in human hepatocellular carcinoma.
Zhou J; Lai PB; Tsui SK
Int J Oncol; 2015 Oct; 47(4):1554-62. PubMed ID: 26238073
[TBL] [Abstract] [Full Text] [Related]
